NDC 58160-823

Shingrix

Zoster Vaccine Recombinant, Adjuvanted

Shingrix is a Kit in the Vaccine category. It is labeled and distributed by Glaxosmithkline Biologicals Sa. The primary component is .

• Product ID: 58160-823_177f1d31-b9d7-4ac1-9e19-45b88bc6ac1e
• NDC: 58160-823
• Product Type: Vaccine
• Proprietary Name: Shingrix
• Generic Name: Zoster Vaccine Recombinant, Adjuvanted
• Dosage Form: Kit
• Marketing Start Date: 2017-10-20
• Marketing Category: BLA / BLA
• Application Number: BLA125614
• Labeler Name: GlaxoSmithKline Biologicals SA
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 58160-823-11

1 KIT in 1 CARTON (58160-823-11) * .5 mL in 1 VIAL (58160-828-03) * .5 mL in 1 VIAL (58160-829-03)

• Marketing Start Date: 2017-10-20
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 58160-823-11 [58160082311]

Shingrix KIT

• Marketing Category: BLA
• Application Number: BLA125614
• Product Type: VACCINE
• Billing Unit: EA
• Marketing Start Date: 2017-10-20

Drug Details

NDC Crossover Matching brand name "Shingrix" or generic name "Zoster Vaccine Recombinant, Adjuvanted"

NDC	Brand Name	Generic Name
50090-3372	Shingrix	Zoster Vaccine Recombinant, Adjuvanted
50090-5147	Shingrix	Zoster Vaccine Recombinant, Adjuvanted
58160-819	Shingrix	Zoster Vaccine Recombinant, Adjuvanted
58160-823	Shingrix	Zoster Vaccine Recombinant, Adjuvanted